Real-time enrollment status for this primary central nervous system lymphoma (pcnsl) clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 11:07 PM UTC
| NCT Number | NCT07082868 |
| Recruiting Status | Recruiting |
| Condition | Primary Central Nervous System Lymphoma (PCNSL) |
| Phase | PHASE1 |
| Target Enrollment | 26 participants |
| Active Locations | 8 sites in the US |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of August 28, 2026: Clinical trial NCT07082868 is currently recruiting participants. This phase1 study for primary central nervous system lymphoma (pcnsl) is actively seeking new participants at 8 locations across the United States. The study is sponsored by Memorial Sloan Kettering Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07082868 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07082868 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.